American Well (AMWL) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
2025 marked a pivotal transformation year, focusing on a unified tech platform, divestiture of non-core activities, and improved revenue quality through contract renewals and new client wins.
Executed over 15 payer contract renewals, including a major 3-year renewal with Elevance, driving commercial momentum.
Positioned to achieve operational efficiency and cash flow breakeven in Q4 2026, supported by strong cash reserves and no debt.
Financial highlights
2025 total revenue was $249.3 million; subscription revenue grew to $132.4 million (53% of total), AMG visit revenue was $94.3 million.
Q4 2025 revenue was $55.3 million; subscription revenue $28.8 million, AMG visit revenue $23.7 million.
Q4 gross margin was 51.2%, a 280 basis point decline year-over-year; full year gross margin was 53%.
Net loss and adjusted EBITDA losses were each reduced by approximately $100 million year-over-year; full year net loss $(95.0)M, improved from $(212.6)M in 2024.
Ended 2025 with $182.3 million in cash and marketable securities and no debt.
Outlook and guidance
2026 revenue guidance is $195–$205 million; AMG visits expected between 1.32–1.37 million.
Adjusted EBITDA loss for 2026 projected at $24–$18 million; Q1 2026 revenue expected at $48–$53 million.
Positive cash flow from operations targeted for Q4 2026.
Guidance assumes continued subscription stability, visit volume trends, cost discipline, and incremental AI-driven efficiencies.
Latest events from American Well
- Q2 2026 revenue hit $52M, net loss narrowed, and positive cash flow is projected for Q4.AMWL
Q2 20264 Aug 2026 - Digital care platform advances risk-based models, grows subscription revenue, and nears DHA global rollout.AMWL
UBS Global Healthcare Conference8 Jul 2026 - Director election, auditor ratification, and executive pay were key AGM agenda items.AMWL
AGM 202616 Jun 2026 - Dr. Roy Schoenberg will not seek re-election, and no substitute director will be nominated.AMWL
Proxy filing9 Jun 2026 - Strong Q1 results and major government contracts position the company for profitable growth by 2027.AMWL
21st Annual Needham Technology, Media, & Consumer Conference14 May 2026 - Q1 2026 revenue fell 18%, but net loss narrowed and positive cash flow is targeted for Q4.AMWL
Q1 20266 May 2026 - Key votes include director elections, auditor ratification, and executive pay approval.AMWL
Proxy filing23 Apr 2026 - 2025 saw major cost reductions, platform innovation, and strong governance ahead of key shareholder votes.AMWL
Proxy filing23 Apr 2026 - 2026 guidance targets $195–$205M revenue, EBITDA breakeven, and strong government contract momentum.AMWL
TD Cowen 46th Annual Health Care Conference3 Mar 2026